Grace Therapeutics Inc (GRCE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2026 | 03-2025 | 03-2024 | 03-2023 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,793 | -9,568 | -12,853 | -42,429 | -9,819 |
| Depreciation Amortization | 7 | 7 | 11 | 124 | N/A |
| Income taxes - deferred | -1,700 | -3,199 | -1,832 | -9,542 | N/A |
| Accounts receivable | 106 | 596 | 80 | -302 | -18 |
| Accounts payable and accrued liabilities | 543 | -84 | -1,652 | 411 | -2,388 |
| Other Working Capital | 719 | 342 | -1,280 | 181 | -2,786 |
| Other Operating Activity | -751 | -2,998 | 5,193 | 35,644 | -2,223 |
| Operating Cash Flow | $-8,869 | $-14,904 | $-12,333 | $-15,913 | $-17,234 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 0 | 15 | 18,185 | -3,522 |
| PPE Investments | N/A | N/A | 89 | -17 | N/A |
| Purchase Sale Intangibles | N/A | N/A | N/A | -5,015 | N/A |
| Other Investing Activity | 0 | 0 | 0 | -5,015 | 0 |
| Investing Cash Flow | $N/A | $0 | $104 | $13,153 | $-3,522 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 4,040 | 14,999 | 7,521 | 304 | N/A |
| Other Financing Activity | -327 | -967 | -162 | 0 | 0 |
| Financing Cash Flow | $3,713 | $14,032 | $7,359 | $304 | $N/A |
| Exchange Rate Effect | N/A | N/A | N/A | -8 | 153 |
| Beginning Cash Position | 22,133 | 23,005 | 27,875 | 30,339 | 50,942 |
| End Cash Position | 16,977 | 22,133 | 23,005 | 27,875 | 30,339 |
| Net Cash Flow | $-5,156 | $-872 | $-4,870 | $-2,464 | $-20,603 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,869 | -14,904 | -12,333 | -15,913 | -17,234 |
| Capital Expenditure | N/A | N/A | -22 | -17 | N/A |
| Free Cash Flow | -8,869 | -14,904 | -12,355 | -15,930 | -17,234 |